The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of disorders involving the testes, pituitary and hypothalamus, it has not been approved for treating age-associated decrease in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the safety of testosterone. The study included approximately 800 elderly men with low testosterone and symptoms associated with this illness, such anti aging supplements (click through the up coming website
) as sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men's heart
health was carefully monitored.
Research has shown that testosterone deficiency is associated with several significant health issues for example metabolic syndrome, obesity, diabetes, and bone fractures Guys who meet medical criteria for treatment should receive therapy. In fact, your testosterone levels have likely been slowly falling for some time, a downfall that generally begins around age 30.
No clear lower limit of testosterone has been established; however 15 ng per dL (0.5 nmol per L) commonly is used. One study 38 found that women with 0 to 10 ng per dL (0 to 0.3 nmol per L) had noticeably decreased sexual desire in all scenarios and absent or markedly reduced climaxes. As a result of studies such as this, supplemented with anecdotal evidence, many women have been started on testosterone treatment. Most girls can expect to spend one third of their lives in the postmenopausal stage. Depression, anger, moodiness, insomnia, and lack of well being are common complaints of postmenopausal women.